Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Healthcare Industry News Lunit submits FDA filing for AI mammography model: What’s next for U.S. breast cancer screening? Find out how Lunit’s FDA-bound artificial intelligence risk model could change breast cancer screening and prevention in the United States. Read the full story. bySrinathDecember 8, 2025